Recent advances in breast cancer radiotherapy

被引：0

作者：

Budach, Wilfried ^{[1
]}

Fourquet, Alain ^{[2
]}

Poortmans, Philip ^{[3
]}

机构：

[1] Inst Curie, Dept Radiat Oncol, Paris, France

[2] Dr Bernard Verbeeten Inst, Dept Radiat Oncol, Tilburg, Netherlands

[3] Univ Hosp, Dept Radiat Oncol, Dusseldorf, Germany

来源：

EJC SUPPLEMENTS | 2008年 / 6卷 / 07期

关键词：

breast cancer; radiotherapy; treatment planning; target volume delineation; organs at risk; multidisciplinary treatment; side effects; breast conserving treatment; postmastectomy radiotherapy; radiochemotherapy;

D O I：

10.1016/S1359-6349(08)70298-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：13 / 14

页数：2

共 10 条

[1]

Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0

[2]

Baum M, 2002, LANCET, V359, P2131

[3] Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: Updated results of a prospective randomized trial [J].

Bellon, JR ;

Come, SE ;

Gelman, RS ;

Henderson, IC ;

Shulman, LN ;

Silver, BJ ;

Harris, JR ;

Recht, A .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (09) :1934-1940

[4] Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy [J].

Donovan, Ellen ;

Bleakley, Natalie ;

Denholm, Erica ;

Evans, Phil ;

Gothard, Lone ;

Hanson, Jane ;

Peckitt, Clare ;

Reise, Stephanie ;

Ross, Gill ;

Sharp, Grace ;

Symonds-Tayler, Richard ;

Tait, Diana ;

Yarnold, John .

RADIOTHERAPY AND ONCOLOGY, 2007, 82 (03) :254-264

[5]

Halyard MY, 2006, J CLIN ONCOL, V24, p8S

[6] Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-con serving surgery and radiotherapy [J].

Kirova, YM ;

Stoppa-Lyonnet, D ;

Sigal-Zafrani, B ;

Fabre, N ;

Fourquet, A .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (15) :2304-2311

[7] Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials [J].

Overgaard, Marie ;

Nielsen, Hanne M. ;

Overgaard, Jens .

RADIOTHERAPY AND ONCOLOGY, 2007, 82 (03) :247-253

[8] Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer [J].

Piccart-Gebhart, MJ ;

Procter, M ;

Leyland-Jones, B ;

Goldhirsch, A ;

Untch, M ;

Smith, I ;

Gianni, L ;

Baselga, J ;

Bell, R ;

Jackisch, C ;

Cameron, D ;

Dowsett, M ;

Barrios, CH ;

Steger, G ;

Huang, CS ;

Andersson, M ;

Inbar, M ;

Lichinitser, M ;

Láng, I ;

Nitz, U ;

Iwata, H ;

Thomssen, C ;

Lohrisch, C ;

Suter, TM ;

Ruschoff, J ;

Süto, T ;

Greatorex, V ;

Ward, C ;

Straehle, C ;

McFadden, E ;

Dolci, MS ;

Gelber, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (16) :1659-1672

[9] Evidence based radiation oncology: Breast cancer [J].

Poortmans, Philip .

RADIOTHERAPY AND ONCOLOGY, 2007, 84 (01) :84-101

[10] Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: Final results of the ARCOSEIN trial [J].

Toledano, Alain ;

Azria, David ;

Garaud, Pascal ;

Fourquet, Alain ;

Serin, Daniel ;

Bosset, Jean-Francois ;

Miny-Buffet, Joelle ;

Favre, Anne ;

Le Floch, Olivier ;

Calais, Gilles .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) :405-410

← 1 →